Apnoea treatment fails to reduce risk in patients with ACS
Study questions the benefit of CPAP for secondary prevention
16th January 2020
Treating obstructive sleep apnoea in patients with acute coronary syndrome may not reduce their risk of cardiovascular events, according to findings from a randomised controlled trial.